Literature DB >> 31338246

Current Status of Management on Pharmacopuncture in Korea through Introduction of an Accreditation System.

Soo-Hyun Sung1, Byung-Cheul Shin2, Min-Jung Park1, Kyeong Han Kim3, Ji-Won Kim1, Ji-Yeon Ryu1, Jang-Kyung Park2.   

Abstract

OBJECTIVES: Pharmacopuncture is a new form of acupuncture treatment that injects herbal medicine into acupuncture points. This paper introduces the management status of pharmacopuncture through accreditation, and examines the effect of accreditation on pharmacopuncture management.
METHODS: The Accreditation System of External Herbal Dispensaries (EHDs) of traditional Korean medicine clinics announced by the Ministry of Health and Welfare in September 2018 were investigated.
RESULTS: The Accreditation System of EHDs assesses and certifies herbal medicine and pharmacopuncture preparations. Regular components for the 'pharmacopuncture' certification consist of nine standards, 30 categories, and 165 items. The nine standards include: herbal dispensary facilities, clean room management, management and organization operation, employee management, document management, continuous quality control, herbal medicine management, management of preparation, and pavement management.
CONCLUSION: Through EHD accreditation and certification system, traditional Korean medicine clinics and EHDs can now manage pharmacopuncture medicine quality and promise safe pharmacopuncture treatment for the people.

Entities:  

Keywords:  EHDs; external herbal dispensaries of traditional Korean medicine clinics; herbal acupuncture; pharmacopuncture

Year:  2019        PMID: 31338246      PMCID: PMC6645342          DOI: 10.3831/KPI.2019.22.009

Source DB:  PubMed          Journal:  J Pharmacopuncture        ISSN: 2093-6966


1. Introduction

Pharmacopuncture, also known as herbal acupuncture, is a new form of acupuncture treatment that injects herbal medicine into acupuncture points [1]. Acupuncture is based on the meridian theory, and herbal medicine is based on the Qi and flavor theories; therefore, pharmacopuncture is based on the traditional medicine theory [2, 3]. Pharmacopuncture has been applied to relieve pain associated with conditions such as rheumatoid arthritis, osteoarthritis, musculoskeletal diseases [4-6], and chronic pelvic pain [7]. Some studies have shown that pharmacopuncture has a significant influence on heart rate variability (HRV) [8-11], type 2 diabetes [12], and cancer [13]. In Korea, pharmacopuncture was first officially introduced to the traditional Korean medicine (TKM) community in 1967 by Sang-Cheon Nam [14]. While conventional acupuncture treatment incorporates the physical stimulation of associated meridians and acupoints, pharmacopuncture adds chemical ingredients from therapeutic herbs with pharmacological effects [2]. In Korea, pharmacopuncture treatment is one of the most commonly used methods in traditional Korean medicine clinics. Of the 123 traditional Korean medicine doctors who are part of the musculoskeletal specialist traditional Korean medicine center, 118 (95.9%) have used pharmacopuncture for the treatment of lumbar disc herniation [15]. A survey of the frequency of pharmacopuncture usage in 4 years at 12 traditional Korean medicine institutions revealed that 32,947 (98.6%) of 33,145 inpatients and 289,860 of 373,755 outpatients (77.6%) received pharmacopuncture [16]. In general, medicinal products are managed by the ministry of food and drug administration (FDA). In Korea, pharmacopuncture is administered based on prescriptions issued by Traditional Korean medicine institutions and external herbal dispensaries (EHDs), facilities of Traditional Korean medicine institutions) to Traditional Korean medicine institutions [17]. Recently, the Korea Ministry of Health and Welfare (MOHW) has announced the introduction of EHDs evaluation accreditation and certification standards. In the certification standard system, two standards are presented: one for evaluating the EHDs of the traditional Korean medicine clinics that prepare pharmacopuncture, and another for evaluating the EHDs that prepare herbal medicine [18]. This paper introduces the management status of pharmacopuncture (traditional Korean medicine treatment) through accreditation, and examines the effect of accreditation on pharmacopuncture management. In addition, we hope this study will serve as a policy reference, and contribute to the institutionalization of traditional medicine.

2. Concept of EHDs

In 2008, the MOHW allowed the establishment of EHDs of medical institutions, and the joint usage of herbal dispensaries [17]. The established EHDs can be used jointly with Traditional Korean medicine institutions, and they play an important role in producing pills, powders, pastes, tablets, pharmacopuncture, etc., which are difficult to prepare in individual Traditional Korean medicine institutions. In December 2017, there were 98 standard EHDs, 15 herbal dispensaries preparing pharmacopuncture, 92 herbal dispensaries preparing herbal medicine, and nine herbal dispensaries preparing pharmacopuncture and herbal medicine [18]. The facility standard and management plan for the herbal dispensaries prepared in 2008 was the minimum standard for the herbal dispensaries of Traditional Korean medicine institutions. The same standard was applied to the EHDs [17]. However, there are aspects to which the current standard does not apply to, like the herbal dispensaries preparing larger and more varied formulations, particularly for pharmacopuncture. In this context, the MOHW introduced autonomous evaluation accreditation in 2018 to assert its own quality control rather than regulating through standard revision [18].

3. Introduction of the Accreditation System of EHDs

The Accreditation System of EHDs introduced in September 2018 assesses and certifies herbal medicine and pharmacopuncture preparations. The accreditation is applied separately to the EHDs preparing herbal medicine and those preparing pharmacopuncture. The EHDs that prepare herbal medicine are evaluated with 81 items reflecting the KGMP (Korean Good Manufacturing Practice for Injection) and Hazard analysis and critical control points (HACCP) standards, and those that prepare pharmacopuncture are evaluated with 165 items according to the KGMP standards. The accreditation system of the EHDs is autonomous, and a certification mark is granted if all the evaluation items are satisfied (Fig. 1). The standards of certification and the certification period are shown in Table 1.
Figure 1

Certification mark of external herbal dispensaries (EHDs) of traditional Korean medicine clinics

Table 1

Criteria of accreditation class of external herbal dispensaries of traditional Korean medicine clinics preparing pharmacopuncture (P-EHDs)

Accreditation classAchievement standards (%)Duration of Accreditation

Accreditation100%3 years
Non-accreditation< 100%Revaluation

4. Evaluation Standards of P-EHDs

Regular components for the ‘pharmacopuncture’ certification consist of nine standards, 30 categories, and 165 items. The nine standards include: herbal dispensary facilities, clean room management, management and organization operation, employee management, document management, continuous quality control, herbal medicine management, management of preparation, and pavement management (Table 2). Details of the certification standard can be found in the “External Herbal Dispensaries Certification Standard” published by the MOHW [18]. The main contents of the nine standards have been briefly summarized below.
Table 2

Evaluation standard of external herbal dispensaries of traditional Korean medicine clinics preparing pharmacopuncture (P-EHDs)

Evaluation CategoriesEvaluation PartsNumber of Evaluation Items
1. Herbal Dispensaries Facilities1.1 Facility Management25
1.2 Preparation Supporting Facilities9
1.3 Storage Facilities2
1.4 Drainage Facilities3
1.5 Prevention of Insect and Heat3
2. Clean Room Management2.1 Classification of Clean Room and Air Conditioning Equipment4
2.2 Monitoring of Clean Room and Air Conditioning Equipment6
2.3 Hygiene Management of Clean Room7
2.4 Working Environment of Pharmacopuncture Preparation7
3. Management and Organization Operation3.1 Organization3
3.2 Business Management4
3.3 Sessions Operation1
4. Employee Management4.1 Education3
4.2 Personal Hygiene Management12
4.3 Infection Control1
5. Document Management5.1 Production of Documents5
5.2 Archiving and Disposing of Documents2
6. Continuous Quality Control6.1 Quality Management System1
6.2 Complaints Management1
7. Herbal Medicine Management7.1 Herbal Medicine Management3
7.2 Storage, Use, and Disposal of Herbal Medicine8
8. Management of Preparation8.1 Process Management 12
8.2 Sterilization Management10
8.3 Filtration Work Management of Pharmacopuncture Preparation5
8.4 Final Work Management of Pharmacopuncture Preparation7
8.5 Examination of Pharmacopuncture6
8.6 Preparation in Advance2
8.7 Checking the Preparation3
9. Packaging Management9.1 Management of Packaging Materials2
9.2 Packaging Operation Management8
TOTAL165

4.1. Herbal Dispensary Facilities

The Herbal Dispensary Facilities standard assesses whether EHDs have the facility base to prepare safe pharmacopuncture. Forty-two evaluation items are divided into seven categories: facility management of herbal dispensaries, preparation support facilities, storage facilities, drainage facilities, lighting, anti-insect, and anti-heat.

4.2. Clean Room Management

The Clean Room Management standard also assesses whether the EHDs have the facilities to prepare safe pharmacopuncture. Twenty-four evaluation items are divided into four categories: classification of clean room and clean air equipment, monitoring of clean room and clean air device, management of clean room sanitation, and pharmacopuncture preparation environment.

4.3. Management and Organization Operation

The Management and Organization Operation standard assesses whether external herbal dispensaries comply with legal workforce standards to provide safe pharmacopuncture. Eight items divided into three categories of organization, management, and operations are evaluated.

4.4. Employee Management

The Employee Management standard assesses whether the EHDs provide opportunities for employee development, qualification maintenance, and professional development. The 16 evaluation items are divided into five categories: education, personal hygiene, shift work, employee complaints, grievance handling, contagion control, and infection control.

4.5. Document Management

The Document Management standard evaluates whether the EHDs are able to perform preparation tasks and hygiene management based on regulations, and whether procedures such as preparation, modification, and approval of various recorded documents are organized. Seven items in two categories of document production and document retention/disposal are evaluated.

4.6. Continuous Quality Control

The Continuous Quality Control standard assesses whether the management system for continuous quality improvement has been established, and the employees have been made aware of it and are evaluating it. Two items in two categories are evaluated: one for the quality management system for improving the quality of prepared pharmacopuncture, and another for handling the complaints and difficulties of the medical institutions.

4.7. Herbal Medicine Management

The Herbal Medicine Management standard evaluates the EHDs for thorough quality control of raw herbal medicines so that safe pharmacopuncture can be prepared. Eleven items in two categories of raw herbal medicine warehousing/inspection and raw herbal medicine storage/use/disposal are evaluated.

4.8. Management of Preparation

The Management of Preparation standard consists of eight evaluation categories and 45 evaluation items. First, in the water management section, water management regulations are established and obeyed to create suitable conditions for preparing safe pharmacopuncture. The four categories of process management, sterilization management, pharmacopuncture filtration, and final task management are composed of 12, 10, 5, and 7 evaluation items, respectively. These evaluate whether conditions for preparing safe pharmacopuncture are created by establishing and obeying the regulations related to preparation.

4.9. Packaging Management

Finally, in the packaging management standard, 10 items in two categories of packaging material management and packaging management are evaluated to assess whether pharmacopuncture is safely delivered in accordance with the packaging management principles in the EHDs.

5. Discussion

Pharmacopuncture is a new form of acutherapy that intends to cure diseases by injecting an extraction composed of one or many herbal medicines, into the meridian points [2, 3]. Although this is similar to the injection method in terms of the mode of administration, pharmacopuncture is based on the theory of traditional Korean medicine, and is practiced by traditional Korean medicine doctors [19]. It differs from injection methods in that the traditional Korean medicine doctors prepare the medicine at the hospital or at a co-contracted EHD, based on the needs of the patient, thereby reflecting the specific characteristic of traditional Korean medicine, patient-oriented treatment. There are two routes through which traditional Korean medicine institutions provide medicine to patients. First, the traditional Korean medicine doctor prescribes medicine manufactured by a pharmaceutical company authorized by the FDA. Second, the traditional Korean medicine doctor directly dispenses and combines the herbal medicine ingredients himself at traditional Korean medicine institutions or EHDs [20, 21]. Medicines provided through the second route are not covered by the national health insurance, which covers 39.0%–2.8% of the traditional Korean medicine clinic prescriptions and 54.7%–64.7% of the traditional Korean medicine hospital prescriptions [22, 23]. In addition, on investigating the non-covered prescriptions given by traditional Korean medicine doctors, the rate of use of pharmacopuncture was found to be 67.5% and that of decoction of medical ingredients, 90% [23]. Since medicines used for pharmacopuncture vary according to the formulation and extraction method of the medical herbs, and are prescribed according to the characteristics and symptoms of the patients, the current provision method proves to be advantageous when compared to the conventional provision method, which manufactures and supplies uniform medicine. Though injection is advantageous in that it can be administered to patients who have difficulty in taking the medicine orally, and can exhibit rapid effects because they do not go through gastrointestinal system, pharmacopuncture medicine requires stricter quality control, when compared to the other formulations [24]. Even if the FDA through the hGMP system approved the medical ingredients of the formulation, management and guidelines for storage and preparation of ingredients during the process of dispensing and hygiene and bacteriological management of facilities that guarantee aseptic medicine preparation are needed [25-27]. Therefore, it is important to strengthen supervision and control the preparation process. In 2018, the MOHW introduced the concept of evaluation certification, and released the certification standard for EHDs, which originally operated autonomously [18]. The certification separates the evaluation of the EHDs that prepare pharmacopuncture medicine from those that prepare oral medicines, intending to strengthen the pharmacopuncture medicine by following the standards of KGMP injective medicine. Originally, the medicines could only be prepared if the preparation room, herbal medicine storage facilities, water supply, drainage facilities, hygienic clothing preparation, and preparation logbook conditions were satisfied [17, 28]. However, as of now, in order to receive the evaluation certification, a quality assurance system that matches with the KGMP level of aseptic preparation in the aseptic drug manufacturing facility, installation of air conditioning, and clean zone management according to ISO international standards, along with validation items, preparation documents, and aseptic management are required [18]. The following items should be considered in the certification system for the continuous quality control of pharmacopuncture medicine. First, verification of the validity of pharmacopuncture medicine is necessary. The current certification system includes the confirmation of aseptic test results of the medicine solution and the medicine preparation in a clean zone according to ISO international standards, as a certification standard for safety management [18]. However, the validity of each and every drug solution is not checked. Although not all procedures such as cell experiments, animal experiments, clinical trials, etc., that are required for FDA drug approval are necessary here, the certification evaluation should verify the minimum clinical evidence for patient treatment. Second, standardization of the medicament containers is necessary. In case of products for FDA approval, appropriate dosage and container specifications for each medicine are verified at the item approval stage [29]. However, currently for pharmacopuncture, the medicine is contained in a variety of containers of different capacities (e.g., 2 ml, 5 ml, 10 ml, and 20 ml) based on the dispensary, lacking a set standard. The WHO guidelines recommend the use of single-dose vials to prevent contamination of the injectate [30]. In addition, the re-use of injection equipment including multi-dose vials and syringes could lead to the transmission of bloodborne viruses such as HIV, HBV, and HCV, as well as bacterial infections and abscesses at the injection site [32]. Therefore, it is necessary to reflect within the certification, the usage of a container that will guarantee only one-time usage for each individual medicine. Third, the preparation procedure of pharmacopuncture medicine must be aseptic. The manufacture of sterile products is required to minimize the risks of microbiological, particulate, and pyrogen contamination worldwide [26]. Additionally, the FDA has been intimated to improve the safety and quality of sterile products [33]. Thus, in order to establish a safety verification system for the practice of pharmacopuncture, the medicines must be managed through a mandatory certification system. The EHD accreditation and certification system embed a safety management system to the traditional preparation methods of pharmacopuncture medicine. The certification system has a great significance in bringing a systemized management to traditional medicine without infringing the traditional medicine preparation methods that incorporate the traditional Korean medicine treatment characteristic of patient-oriented treatment, and in establishing a safety management system.

6. Conclusion

In this time when pharmacopuncture medicine is being manufactured without specific standards, the EHD accreditation and certification system for medicine safety has been introduced. Through this system, traditional Korean medicine clinics and EHDs can now manage pharmacopuncture medicine quality and promise safe pharmacopuncture treatment for the people. It is our hope that in the future, the certification system will set in through voluntary and continuous involvement of herbal dispensaries, and will bring improvement of pharmacopuncture medicine quality control.
  12 in total

Review 1.  Regulation and quality control of herbal drugs in Korea.

Authors:  Don Woong Choi; Jong Hwan Kim; So Yean Cho; Dal Hwan Kim; Seung Yeup Chang
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

Review 2.  Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.

Authors:  David Hussong
Journal:  AAPS PharmSciTech       Date:  2010-09-16       Impact factor: 3.246

Review 3.  A descriptive statistical approach to the Korean pharmacopuncture therapy.

Authors:  Jungdae Kim; Dae-In Kang
Journal:  J Acupunct Meridian Stud       Date:  2010-09

4.  Effects of Distilled Cervi Pantotrichum Cornu and Rehmannia glutinosa Pharmacopuncture at GB21 (Jianjing) on Heart Rate Variability: A Randomized and Double-blind Clinical Trial.

Authors:  Young-Joo Kim; Chang-Hyun Lee; Jong-Uk Kim; Tae-Han Yook
Journal:  J Acupunct Meridian Stud       Date:  2016-11-10

Review 5.  Research on Korean Pharmacopuncture in South Korea since 2007.

Authors:  ChungSan Lim; SangKyun Park; SeungHo Sun; KwangHo Lee
Journal:  J Pharmacopuncture       Date:  2014-12

6.  Usage report of pharmacopuncture in musculoskeletal patients visiting Korean medicine hospitals and clinics in Korea.

Authors:  Yoon Jae Lee; Joon-Shik Shin; Jinho Lee; Me-Riong Kim; Ki Byung Park; Hwa Dong Lee; Yoonmi Lee; Jungwan Hong; In-Hyuk Ha
Journal:  BMC Complement Altern Med       Date:  2016-08-17       Impact factor: 3.659

7.  Herbal acupuncture for type 2 diabetes: A meta-analysis.

Authors:  Seung-Wook Lee; Min-Ho Nam; Byung-Cheol Lee
Journal:  Exp Ther Med       Date:  2017-04-25       Impact factor: 2.447

8.  A survey among Korea Medicine doctors (KMDs) in Korea on patterns of integrative Korean Medicine practice for lumbar intervertebral disc displacement: Preliminary research for clinical practice guidelines.

Authors:  Ye-sle Shin; Joon-Shik Shin; Jinho Lee; Yoon Jae Lee; Me-riong Kim; Yong-jun Ahn; Ki Byung Park; Byung-Cheul Shin; Myeong Soo Lee; Joo-Hee Kim; Jae-Heung Cho; In-Hyuk Ha
Journal:  BMC Complement Altern Med       Date:  2015-12-07       Impact factor: 3.659

Review 9.  Pharmacopuncture for cancer care: a systematic review.

Authors:  Soyeon Cheon; Xiuyu Zhang; In-Seon Lee; Seung-Hun Cho; Younbyoung Chae; Hyangsook Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-12       Impact factor: 2.629

Review 10.  Pharmacopuncture in Korea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jimin Park; Hyangsook Lee; Byung-Cheul Shin; Myeong Soo Lee; Boryang Kim; Jong-In Kim
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-06       Impact factor: 2.629

View more
  8 in total

1.  Current status and future perspective of external herbal dispensaries preparing traditional herbal medicine in South Korea: the first National-Wide Survey results.

Authors:  Soo-Hyun Sung; Ji-Eun Han; Ji-Yeon Ryu; Angela Dong-Min Sung; Jung-Youn Park; In-Hyuk Ha; Kyeong Han Kim; Jang-Kyung Park; Byung-Cheul Shin
Journal:  BMC Complement Med Ther       Date:  2020-11-23

Review 2.  Animal Venom for Medical Usage in Pharmacopuncture in Korean Medicine: Current Status and Clinical Implication.

Authors:  Soo-Hyun Sung; Ji-Won Kim; Ji-Eun Han; Byung-Cheul Shin; Jang-Kyung Park; Gihyun Lee
Journal:  Toxins (Basel)       Date:  2021-02-01       Impact factor: 4.546

3.  Effects of American wild ginseng and Korean cultivated wild ginseng pharmacopuncture extracts on the regulation of C2C12 myoblasts differentiation through AMPK and PI3K/Akt/mTOR signaling pathway.

Authors:  Ji Hye Hwang; Seok Yong Kang; Hyo Won Jung
Journal:  Mol Med Rep       Date:  2022-04-08       Impact factor: 3.423

4.  Evaluation of Genotoxicity of SU-Eohyeol Pharmacopuncture Using an In Vitro Chromosome Aberration Test in Chinese Hamster Lung Cell.

Authors:  Jaseung Ku; Ji Hye Hwang
Journal:  J Pharmacopuncture       Date:  2022-09-30

5.  Single-Dose Intramuscular Toxicity Study of SU-Eohyeol Pharmacopuncture in Rats.

Authors:  Ji Hye Hwang; Jaseung Ku; Chul Jung
Journal:  J Pharmacopuncture       Date:  2022-09-30

6.  Quality Control of Pharmacopuncture: A Comparative Study of Good Manufacturing Practice and External Herbal Dispensary Standards.

Authors:  Ji-Eun Han; Minjung Park; Tteul-E-Bom An; Jong-Hyun Park; Danny Oh; Kyeong Han Kim; Soo-Hyun Sung
Journal:  J Pharmacopuncture       Date:  2021-06-30

Review 7.  Panax ginseng Pharmacopuncture: Current Status of the Research and Future Challenges.

Authors:  In-Seon Lee; Ki Sung Kang; Song-Yi Kim
Journal:  Biomolecules       Date:  2019-12-25

8.  Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study.

Authors:  Kyeonghan Kim; Hyein Jeong; Gihyun Lee; Soobin Jang; Taehan Yook
Journal:  Toxins (Basel)       Date:  2021-12-27       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.